OpenURL Connection Search

Select item for more details and to access through your institution.

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1931, doi. 10.1007/s00259-019-04358-9
By:
- Verhoeff, Sarah R.;
- van Es, Suzanne C.;
- Boon, Eline;
- van Helden, Erik;
- Angus, Lindsay;
- Elias, Sjoerd G.;
- Oosting, Sjoukje F.;
- Aarntzen, Erik H.;
- Brouwers, Adrienne H.;
- Kwee, Thomas C.;
- Heskamp, Sandra;
- Hoekstra, Otto S.;
- Verheul, Henk;
- van der Veldt, Astrid A. M.;
- de Vries, Elisabeth G. E.;
- Boerman, Otto C.;
- van der Graaf, Winette T. A.;
- Oyen, Wim J. G.;
- van Herpen, Carla M. L.
Publication type:
Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244640
By:
- van Es, Suzanne C.;
- Velleman, Ton;
- Elias, Sjoerd G.;
- Bensch, Frederike;
- Brouwers, Adrienne H.;
- Glaudemans, Andor W. J. M.;
- Kwee, Thomas C.;
- Woltman-van Iersel, Marleen;
- Maduro, John H.;
- Oosting, Sjoukje F.;
- de Vries, Elisabeth G. E.;
- Schröder, Carolina P.
Publication type:
Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244640
By:
- van Es, Suzanne C.;
- Velleman, Ton;
- Elias, Sjoerd G.;
- Bensch, Frederike;
- Brouwers, Adrienne H.;
- Glaudemans, Andor W. J. M.;
- Kwee, Thomas C.;
- Woltman-van Iersel, Marleen;
- Maduro, John H.;
- Oosting, Sjoukje F.;
- de Vries, Elisabeth G. E.;
- Schröder, Carolina P.
Publication type:
Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244640
By:
- van Es, Suzanne C.;
- Velleman, Ton;
- Elias, Sjoerd G.;
- Bensch, Frederike;
- Brouwers, Adrienne H.;
- Glaudemans, Andor W. J. M.;
- Kwee, Thomas C.;
- Iersel, Marleen Woltman-van;
- Maduro, John H.;
- Oosting, Sjoukje F.;
- de Vries, Elisabeth G. E.;
- Schröder, Carolina P.
Publication type:
Article
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
By:
- van Es, Suzanne C.;
- Brouwers, Adrienne H.;
- Mahesh, Shekar V. K.;
- Leliveld-Kors, Annemarie M.;
- de Jong, Igle J.;
- Lub-de Hooge, Marjolijn N.;
- de Vries, Elizabeth G. E.;
- Gietema, Jourik A.;
- Oosting, Sjoukje F.
Publication type:
Article
Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.
Published in:
Journal of Nuclear Medicine, 2016, v. 57, p. 96S, doi. 10.2967/jnumed.115.157974
By:
- van Es, Suzanne C.;
- Venema, Clasina M.;
- Glaudemans, Andor W. J. M.;
- Lub-de Hooge, Marjolijn N.;
- Elias, Sjoerd G.;
- Boellaard, Ronald;
- Hospers, Geke A. P.;
- Schröder, Carolina P.;
- de Vries, Elisabeth G. E.
Publication type:
Article
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
By:
- Oosting, Sjoukje F.;
- Brouwers, Adrienne H.;
- van Es, Suzanne C.;
- Nagengast, Wouter B.;
- Munnink, Thijs H. Oude;
- Lub-de Hooge, Marjolijn N.;
- Hollema, Harry;
- de Jong, Johan R.;
- de Jong, Igle J.;
- de Haas, Sanne;
- Scherer, Stefan J.;
- Sluiter, Wim J.;
- Dierckx, Rudi A.;
- Bongaerts, Alfons H. H.;
- Gietema, Jourik A.;
- de Vries, Elisabeth G. E.
Publication type:
Article

Found: 7

Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.

Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.

Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.

Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.

<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.

Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.

<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.